Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Ducommun (NYSE:DCO) in the last three months.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $127.25, a high estimate of $142.00, and a low estimate of $110.00. Observing a 16.74% increase, the current average has risen from the previous average price target of $109.00.

Diving into Analyst Ratings: An In-Depth Exploration

An in-depth analysis of recent analyst actions unveils how financial experts perceive Ducommun. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ducommun's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Ducommun analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Unveiling the Story Behind Ducommun

Key Indicators: Ducommun's Financial Health

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Over the 3M period, Ducommun showcased positive performance, achieving a revenue growth rate of 5.53% as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Ducommun's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -30.32% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -9.5%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Ducommun's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -5.39%, the company may face hurdles in achieving optimal financial returns.

Debt Management: Ducommun's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.42.

The Core of Analyst Ratings: What Every Investor Should Know

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.